Revisiting resistant hypertension in kidney disease.

Curr Opin Nephrol Hypertens · 2024 · PMC11296285 · PMID 38726750

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

possibly significantno p-value reported

Nonetheless, the benefits of successful treatment are possibly significant as suggested by data from the Systolic Blood Pressure Intervention Trial (SPRINT) study [ 31 ], although needs definitive evaluation in resistant hypertension associated with CKD.

also in 160 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.